FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 62 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,866,000 | +44.5% | 70,059 | +6.4% | 0.01% | +37.5% |
| Q2 2017 | $1,983,000 | -7.6% | 65,851 | +10.9% | 0.01% | -11.1% |
| Q1 2017 | $2,147,000 | -25.7% | 59,400 | +3.1% | 0.01% | -25.0% |
| Q4 2016 | $2,888,000 | +1.7% | 57,629 | +6.6% | 0.01% | 0.0% |
| Q3 2016 | $2,839,000 | +35.6% | 54,082 | +6.9% | 0.01% | +33.3% |
| Q2 2016 | $2,093,000 | +16.9% | 50,610 | +14.9% | 0.01% | +12.5% |
| Q1 2016 | $1,790,000 | -3.6% | 44,050 | -1.5% | 0.01% | 0.0% |
| Q4 2015 | $1,856,000 | +155.3% | 44,726 | -5.4% | 0.01% | +166.7% |
| Q3 2015 | $727,000 | -39.1% | 47,259 | -1.6% | 0.00% | -40.0% |
| Q2 2015 | $1,193,000 | +13.0% | 48,019 | +3.9% | 0.01% | +25.0% |
| Q1 2015 | $1,056,000 | +13.8% | 46,198 | +34.4% | 0.00% | 0.0% |
| Q4 2014 | $928,000 | +116.3% | 34,386 | -5.9% | 0.00% | +100.0% |
| Q3 2014 | $429,000 | -18.6% | 36,546 | +7.8% | 0.00% | 0.0% |
| Q2 2014 | $527,000 | +3.3% | 33,896 | +30.5% | 0.00% | 0.0% |
| Q1 2014 | $510,000 | +618.3% | 25,966 | +517.8% | 0.00% | – |
| Q4 2013 | $71,000 | – | 4,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|